Floating Button
Home News Philanthropy

New report calls for collective action to fight ‘silent pandemic’ of Asia’s growing antimicrobial resistance

Jovi Ho
Jovi Ho • 3 min read
New report calls for collective action to fight ‘silent pandemic’ of Asia’s growing antimicrobial resistance
In Asia Pacific, related costs are projected to reach up to US$700 billion by 2050. However, timely investment could generate between US$10 billion and US$15 billion in annual healthcare savings. Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

A new report by Temasek Trust initiatives calls for more funding to tackle antimicrobial resistance in Asia (AMR), which could become the leading cause of death by 2050. The report, released May 5, outlines four key areas where funders can drive meaningful impact - from education and prevention to surveillance and treatment.

"Antimicrobial resistance is on track to become the deadliest health threat facing humanity. But with urgent action and targeted finance, over 100 million deaths could be prevented by 2050," reads the report by the Centre for Impact Investing and Practices (CIIP) and the World Economic Forum's GAEA (Giving to Amplify Earth Action) initiative, supported by the Philanthropy Asia Alliance (PAA).

Rising temperatures and extreme weather events are accelerating bacterial growth and disease transmission, while disrupting healthcare and immunisation services, say the report's authors. Climate-related pressures are also driving the increased use of antimicrobials in livestock and crops, contaminating freshwater sources and fuelling drug resistance, they add.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.